Hendrix Genetics Swine and Porcigenes Strengthen Their Alliance at PorkAmericas 2026

Published on Aug. 17, 2026

Hendrix Genetics Swine and Porcigenes Strengthen Their Alliance at PorkAmericas 2026

This article was originally written and published by 3tres3. It is shared here with their permission.

Hendrix Genetics Swine and Porcigenes strengthen their alliance at PorkAmericas 2026 to drive a new era of Swine Genetics in Colombia. Both companies commitment to the development of Colombian swine production, presenting a proposal based on new technologies and genetic innovation.

PorkAmericas 2026 once again established itself as one of the leading platforms for knowledge exchange, innovation, and the strengthening of strategic alliances within the Latin American swine industry. In this context, Hendrix Genetics Swine participated alongside its strategic partner in Colombia, Porcigenes, reinforcing the joint work both companies carry out to bring high-value genetic solutions to producers across the country.

The presence at the event allowed both companies to share with clients, producers, and industry professionals the vision of Hendrix Genetics Swine regarding the new challenges facing swine production, at a time of transformation for the company following the integration of Hypor and Danish Genetics — an evolution that strengthens their portfolio with technologies and products aimed at improving the productivity, efficiency, and profitability of production systems.

As part of the congress' academic agenda, Nelson Adrian Restrepo, General Manager Latam at Hendrix Genetics Swine, participated as a speaker at the Swine Genetics Forum: "Where are we?: Sustainable Prolificacy, Disease Resistance, Robustness, Gene Editing, Animal Welfare, and Behavior", a session in which industry experts analyzed the main trends shaping the future of swine genetics and the challenges the sector will face in the coming years.

During the event, Hendrix Genetics Swine and Porcigenes highlighted that Colombia is entering a new phase in swine genetics, marked by the incorporation of new technologies and a broader genetic offering designed to meet the real needs of Colombian producers and adapt to different production systems.

Nexus 100: Innovation for the Region's Production Systems

One of the main pillars of this evolution is Nexus 100, the new genetic line developed by Hendrix Genetics Swine bringing a balanced genetic solution to Latin American market.

Nexus 100 combines the renowned adaptability and hardiness of the Hypor lines with the high prolificacy of Danish genetics, offering a solution designed to achieve a balance between productivity, ease of management, and economic efficiency.

Its development responds to a clear objective: to provide producers with a sow capable of producing more piglets without compromising fundamental aspects such as feed intake, maternal capacity, milk production, and adaptation to the region's production conditions.

Participation in PorkAmericas 2026 reaffirms the commitment of Hendrix Genetics Swine and Porcigenes to continue working together to bring genetic innovation, knowledge, and technical support to Colombian producers, contributing to the sustainable and competitive growth of the national swine industry.

Read the original article here

Related articles

, by
Beyond “Extreme Breeding”: The Future of Danish Pig Production Is Already Here

The debate around “extreme breeding” has become one of the most prominent discussions in Danish agriculture. Critics point to large litter sizes, high piglet mortality, and the challenge of sows rais…

, by
Maximizing Sow Productive Lifetime for Sustainable Swine Production

Sow Productive Lifetime refers to the duration a sow remains productive before exiting the herd. Key factors such as health, nutrition, environment, management, and genetics significantly impact a so…

, by
The Nexus 100: A Balanced Sow for Modern Pig Production

Modern pig production is evolving rapidly, and with it, the challenges producers face on a daily basis. Operations are confronted with increasing variability in performance, higher health risks, labo…